prikaz prve stranice dokumenta Inhaled therapies in patients with moderate COPD in clinical practice: current thinking
  Preuzmi
PDF 403.91 KB
Znanstveni rad - Izvorni znanstveni rad
Inhaled therapies in patients with moderate COPD in clinical practice: current thinking
International Journal of Chronic Obstructive Pulmonary Disease, 13 (2017); 45-56. https://doi.org/10.2147/COPD.S145573
Ariel, Amnon; Altraja, Alan; Belevskiy, Andrey; Boros, Piotr; Danila, Edvardas; Flezar, Matjaz; Koblizek, Vladimir; Fridlender, Zvi Gregorio; Kostov, Kosta; Krams, Alvils; Milenkovic, Branislava; Somfay, Attila; Tkacova, Ruzena; Tudorić, Neven; Ulmeanu, Ruxandra; Valipour, Arschang Više autora...

Citirajte ovaj rad

Ariel, A., Altraja, A., Belevskiy, A., Boros, P., Danila, E., Flezar, M. ... Valipour, A. (2017). Inhaled therapies in patients with moderate COPD in clinical practice: current thinking. International Journal of Chronic Obstructive Pulmonary Disease, 13., 45-56. doi: 10.2147/COPD.S145573

Ariel, Amnon, et al. "Inhaled therapies in patients with moderate COPD in clinical practice: current thinking." International Journal of Chronic Obstructive Pulmonary Disease, vol. 13, 2017, str. 45-56. https://doi.org/10.2147/COPD.S145573

Ariel, Amnon, Alan Altraja, Andrey Belevskiy, Piotr Boros, Edvardas Danila, Matjaz Flezar, Vladimir Koblizek, et al. "Inhaled therapies in patients with moderate COPD in clinical practice: current thinking." International Journal of Chronic Obstructive Pulmonary Disease 13 (2017): 45-56. https://doi.org/10.2147/COPD.S145573

Ariel, A., et al. (2017) 'Inhaled therapies in patients with moderate COPD in clinical practice: current thinking', International Journal of Chronic Obstructive Pulmonary Disease, 13, str. 45-56. doi: 10.2147/COPD.S145573

Ariel A, Altraja A, Belevskiy A, Boros P, Danila E, Flezar M, i sur.. Inhaled therapies in patients with moderate COPD in clinical practice: current thinking. International Journal of Chronic Obstructive Pulmonary Disease [Internet]. 21.12.2017. [pristupljeno 06.05.2024.];13:45-56. doi: 10.2147/COPD.S145573

A. Ariel, et al., "Inhaled therapies in patients with moderate COPD in clinical practice: current thinking", International Journal of Chronic Obstructive Pulmonary Disease, vol. 13, str. 45-56, Prosinac 2017. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:888485. [Citirano: 06.05.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:888485
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Inhaled therapies in patients with moderate COPD in clinical practice: current thinking
AutorAmnon Ariel
AutorAlan Altraja
AutorAndrey Belevskiy
AutorPiotr Boros
AutorEdvardas Danila
AutorMatjaz Flezar
AutorVladimir Koblizek
AutorZvi Gregorio Fridlender
AutorKosta Kostov
AutorAlvils Krams
AutorBranislava Milenkovic
AutorAttila Somfay
AutorRuzena Tkacova
AutorNeven Tudorić
AutorRuxandra Ulmeanu
AutorArschang Valipour
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Sažetak (engleski)
COPD is a complex, heterogeneous condition. Even in the early clinical stages, COPD carries a significant burden, with breathlessness frequently leading to a reduction in exercise capacity and changes that correlate with long-term patient outcomes and mortality. Implementation of an effective management strategy is required to reduce symptoms, preserve lung function, quality of life, and exercise capacity, and prevent exacerbations. However, current clinical practice frequently differs from published guidelines on the management of COPD. This review focuses on the current scientific evidence and expert opinion on the management of moderate COPD: the symptoms arising from moderate airflow obstruction and the burden these symptoms impose, how physical activity can improve disease outcomes, the benefits of dual bronchodilation in COPD, and the limited evidence for the benefits of inhaled corticosteroids in this disease. We emphasize the importance of maximizing bronchodilation in COPD with inhaled dual-bronchodilator treatment, enhancing patient-related outcomes, and enabling the withdrawal of inhaled corticosteroids in COPD in well-defined patient groups.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaInternational Journal of Chronic Obstructive Pulmonary Disease
Brojčani podacivol. 13, str. 45-56
p-ISSN1178-2005
DOIhttps://doi.org/10.2147/COPD.S145573
URN:NBNurn:nbn:hr:105:888485
Datum objave publikacije2017-12-21
URL dokumentahttps://doi.org/10.2147/COPD.S145573
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2024-03-28 10:09:58